ETF Holdings Breakdown of AZN

Stock NameAstraZeneca PLC
TickerAZN(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0009895292
LEIPY6ZZQWO2IZFZC3IOL08

News associated with AZN

AstraZeneca's New Asthma Treatment Shows Strong Results In Late-stage Trials
(RTTNews) - AstraZeneca Plc.'s (AZN.L, AZN) triple-combination inhaler, Breztri Aerosphere, has shown positive results in late-stage clinical trials for patients with uncontrolled asthma. The trials, called KALOS and LOGOS, found that the inhaler significantly improved lung funct - 2025-05-02 06:24:44
CANADA LIFE ASSURANCE Co Has $49,000 Position in AstraZeneca PLC (NASDAQ:AZN)
CANADA LIFE ASSURANCE Co reduced its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 29.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 742 shares of the company’s stock after selling 305 shares during the period. CANADA […] - 2025-05-01 08:50:47
Shore Capital Reaffirms Buy Rating for AstraZeneca (LON:AZN)
AstraZeneca (LON:AZN – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Shore Capital in a note issued to investors on Tuesday, MarketBeat reports. Several other equities analysts have also issued reports on the company. Berenberg Bank reaffirmed a “buy” rating and set a GBX 140 ($1.87) price target on shares […] - 2025-05-01 05:46:46
Daiichi Sankyo, AstraZeneca's Enhertu Plus Pertuzumab Shows Positive Results In Breast Cancer Trial
(RTTNews) - Daiichi Sankyo Co., Ltd. (DSKYF.PK) announced Monday that Enhertu (trastuzumab deruxtecan), co-developed and commercialized with British drug major AstraZeneca Plc. (AZN.L, AZN), Plus Pertuzumab showed positive topline results in a phase 3 trial in breast cancer patie - 2025-04-21 07:01:44
AstraZeneca PLC (NASDAQ:AZN) Receives $89.75 Average PT from Brokerages
AstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ten brokerages that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and two have issued a strong buy rating on the company. […] - 2025-04-09 05:54:54
Corebridge Financial Inc. Sells 206 Shares of AstraZeneca PLC (NASDAQ:AZN)
Corebridge Financial Inc. lowered its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 0.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 37,867 shares of the company’s stock after selling 206 shares during the quarter. Corebridge Financial Inc.’s holdings in AstraZeneca were worth $2,481,000 as of its most recent filing with the Securities […] - 2025-04-02 07:46:50
Nasdaq 100 Movers: AZN, TSLA
In early trading on Monday, shares of Tesla topped the list of the day's best performing components of the Nasdaq 100 index, trading up 6.2%. Year to date, Tesla has lost about 34.6% of its value. And the worst performing Nasdaq 100 component thus far on the day is AstraZeneca - 2025-03-24 15:58:09
Brokerages Set AstraZeneca PLC (LON:AZN) PT at GBX 7,542.80
Shares of AstraZeneca PLC (LON:AZN – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year […] - 2025-03-24 06:40:48
Independent Advisor Alliance Purchases 442 Shares of AstraZeneca PLC (NASDAQ:AZN)
Independent Advisor Alliance increased its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,847 shares of the company’s stock after acquiring an additional 442 shares during the quarter. Independent Advisor […] - 2025-03-20 08:24:52
Wealthfront Advisers LLC Acquires New Position in AstraZeneca PLC (NASDAQ:AZN)
Wealthfront Advisers LLC acquired a new stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 4,567 shares of the company’s stock, valued at approximately $299,000. Other institutional investors have also recently made changes […] - 2025-03-18 08:55:01
Validea Detailed Fundamental Analysis - AZN
Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that e - 2025-03-17 14:37:22
Guru Fundamental Report for AZN
Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that e - 2025-03-13 14:42:07
AstraZeneca PLC (NASDAQ:AZN) Given Average Rating of “Buy” by Analysts
AstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been given an average recommendation of “Buy” by the ten ratings firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and two have issued a strong buy recommendation on […] - 2025-03-12 06:41:27
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by New York State Common Retirement Fund
New York State Common Retirement Fund grew its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 7.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 133,043 shares of the company’s stock after acquiring an additional 9,124 shares during the quarter. New York State Common Retirement Fund’s holdings in AstraZeneca were worth $8,717,000 at […] - 2025-02-26 09:36:56
AstraZeneca's Camizestrant Shows Positive Interim Results In SERENA-6 Phase 3 Trial
(RTTNews) - AstraZeneca plc (AZN, AZN.L), on Wednesday, reported positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial of Of Camizestrant. - 2025-02-26 07:25:06
AstraZeneca PLC (LON:AZN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of AstraZeneca PLC (LON:AZN – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price […] - 2025-02-24 08:29:04
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by J.W. Cole Advisors Inc.
J.W. Cole Advisors Inc. reduced its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 17.5% in the 4th quarter, Holdings Channel reports. The firm owned 4,542 shares of the company’s stock after selling 964 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in AstraZeneca were worth $298,000 as of its most recent SEC […] - 2025-02-21 10:28:53
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Allworth Financial LP
Allworth Financial LP boosted its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 12.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,768 shares of the company’s stock after purchasing an additional 1,461 shares during the period. Allworth Financial LP’s holdings in AstraZeneca were […] - 2025-02-20 10:18:53
Sumitomo Mitsui Trust Group Inc. Has $5.58 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Sumitomo Mitsui Trust Group Inc. grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 0.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 85,127 shares of the company’s stock after purchasing an additional 616 shares during the quarter. Sumitomo […] - 2025-02-14 09:35:09
Kingsview Wealth Management LLC Has $805,000 Holdings in AstraZeneca PLC (NASDAQ:AZN)
Kingsview Wealth Management LLC cut its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,279 shares of the company’s stock after selling 675 shares during the period. […] - 2025-02-13 09:52:55
Stephens Inc. AR Trims Position in AstraZeneca PLC (NASDAQ:AZN)
Stephens Inc. AR lessened its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.2% in the fourth quarter, Holdings Channel reports. The fund owned 24,987 shares of the company’s stock after selling 1,360 shares during the quarter. Stephens Inc. AR’s holdings in AstraZeneca were worth $1,637,000 as of its most recent filing […] - 2025-02-13 08:56:50
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Stratos Wealth Partners LTD.
Stratos Wealth Partners LTD. decreased its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,476 shares of the company’s stock after selling 835 shares during the period. Stratos Wealth Partners LTD.’s holdings in […] - 2025-02-11 10:34:50
Yousif Capital Management LLC Sells 1,500 Shares of AstraZeneca PLC (NASDAQ:AZN)
Yousif Capital Management LLC lowered its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 4.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,843 shares of the company’s stock after selling 1,500 shares during the quarter. Yousif Capital Management […] - 2025-02-11 08:40:57
DAVENPORT & Co LLC Sells 518 Shares of AstraZeneca PLC (NASDAQ:AZN)
DAVENPORT & Co LLC decreased its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 3.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,017 shares of the company’s stock after selling 518 shares during the period. DAVENPORT & Co LLC’s […] - 2025-02-07 11:05:13
AstraZeneca (LON:AZN) Stock Passes Above Two Hundred Day Moving Average – Here’s What Happened
AstraZeneca PLC (LON:AZN – Get Free Report)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of £114.96 ($142.96) and traded as high as £119.78 ($148.96). AstraZeneca shares last traded at £117.86 ($146.57), with a volume of 2,997,711 shares. Analyst Upgrades and Downgrades A […] - 2025-02-07 08:35:57
AstraZeneca: CHMP Recommends Approval Of Imfinzi In The EU
(RTTNews) - AstraZeneca (AZN.L, AZN) announced Imfinzi was recommended for approval in the European Union by CHMP as first and only immunotherapy for limited-stage small cell lung cancer. The CHMP of the European Medicines Agency based its positive opinion on the results from the - 2025-02-03 07:23:49
Fifth Third Bancorp Reduces Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
Fifth Third Bancorp lowered its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 66.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,538 shares of the company’s stock after selling 11,164 shares during the period. Fifth Third Bancorp’s […] - 2025-01-31 08:47:03

AZN institutional holdings

The following institutional investment holdings of AZN have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00B53SZB19 (iShares NASDAQ 100 UCITS ETF USD (Acc)) 671,372USD 45,183,336
2025-05-08 IE00BYVQ9F29 (iShares NASDAQ 100 UCITS ETF) 671,372 0.1%USD 45,183,336 -4.0%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 277,146USD 18,651,926
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 277,146USD 18,651,926 -4.1%
2024-12-10 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 2,064,301 0.3%GBP 276,446,285 -1.9%
2024-12-10 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 2,064,301 0.3%GBP 276,446,285 -1.9%
2024-12-10 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 2,064,301 0.3%GBP 276,446,285 -1.9%
2024-12-10 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 337,853 0.2%GBP 45,244,471 -2.1%
2024-12-10 IE0005042456 (iShares Core FTSE 100 UCITS ETF GBP (Dist)) 8,326,129GBP 875,242,680 -1.8%
2024-12-10 IE00BYZ28W67 (iShares Core FTSE 100 UCITS USD Hedged (Acc)) 8,326,129GBP 875,242,680 -1.8%
2024-12-10 IE00B1YZSC51 (iShares Core MSCI Europe UCITS ETF EUR (Dist)) 1,276,348GBP 162,716,447 -1.4%
2024-12-10 IE00BL4KKW48 (iShares Core MSCI Europe UCITS ETF MXN Hedged (Acc)) 1,276,348GBP 162,716,447 -1.4%
2024-12-10 IE00B4K48X80 (iShares Core MSCI Europe UCITS ETF EUR (Acc)) 1,185,503GBP 151,134,985 -1.4%
2024-12-10 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 164,350GBP 22,009,362 -2.3%
2024-12-10 IE00BHZPJ676 (iShares MSCI Europe ESG Enhanced UCITS ETF EUR Inc GBP) 903,190GBP 115,144,042 -1.4%
2024-12-10 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 68,945GBP 9,232,951 -2.3%
2024-12-10 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 68,945GBP 9,232,951 -2.3%
2024-12-10 IE00BP3QZ601 (iShares Edge MSCI World Quality Factor UCITS ETF) 168,647GBP 22,584,806 -2.3%
2024-12-10 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 106,596 0.7%GBP 14,275,083 -1.6%
2024-12-10 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 106,596 0.7%GBP 14,275,083 -1.6%
2024-12-10 IE00BFNM3D14 (iShares MSCI Europe ESG Screened UCITS ETF EUR (Acc) GBP) 547,745 0.1%GBP 69,829,796 -1.3%
2024-12-10 IE00BFNM3F38 (iShares MSCI Europe ESG Screened UCITS ETF) 547,745 0.1%GBP 69,829,796 -1.3%
2024-12-10 IE00B53HP851 (iShares Core FTSE 100 UCITS ETF GBP (Acc)) 1,611,390GBP 169,389,317 -1.8%
2024-12-10 IE00BD3RYZ16 (iShares OMX Stockholm Capped UCITS ETF) 34,394SEK 50,748,347 -1.2%
2024-12-10 IE00B57X3V84 (iShares Dow Jones Global Sustainability Screened UCITS ETF USD (Acc)) 105,851GBP 14,175,314 -2.3%
2024-12-10 IE00BKVL7778 (iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)) 7,932GBP 1,062,235 -2.3%
2024-12-10 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 208,696 -1.0%GBP 27,948,072 -3.3%
2024-12-10 IE00B86MWN23 (iShares Edge MSCI Europe Minimum Volatility UCITS ETF EUR (Acc) USD) 74,670GBP 9,519,376 -1.4%
2024-12-10 IE00BG13YK79 (iShares Edge MSCI Europe Minimum Volatility UCITS ETF EUR (Dist)) 74,670GBP 9,519,376 -1.4%
2024-12-10 DE000A0Q4R36 (iShares STOXX Europe 600 Health Care UCITS ETF DE) 617,298GBP 78,696,827 -1.4%
2024-12-10 IE00BMW42181 (iShares MSCI Europe Health Care Sector UCITS ETF) 547,209GBP 69,761,463 -1.4%
2024-12-10 IE0008470928 (iShares STOXX Europe 50 UCITS ETF EUR (Dist)) 173,327 -1.5%GBP 22,096,759 -2.9%
2024-12-10 IE00BQN1K562 (iShares Edge MSCI Europe Quality Factor UCITS ETF) 126,818GBP 16,167,514 -1.4%
2024-12-10 IE00BG13YG34 (iShares Edge MSCI Europe Quality Factor UCITS Dist) 126,818GBP 16,167,514 -1.4%
2024-12-10 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 8,913GBP 936,935 -1.8%
2024-12-10 IE00B539F030 (iShares MSCI UK UCITS ETF) 70,497GBP 7,410,645 -1.8%
2024-12-10 IE00BKVL7D31 (iShares Edge MSCI Europe Minimum Volatility ESG UCITS ETF EUR (Acc)) 5,549GBP 707,420 -1.4%
2024-12-10 IE00BMDBM966 (iShares Edge MSCI Europe Minimum Volatility ESG UCITS ETF) 5,549GBP 707,420 -1.4%
2024-12-10 IE00BMDBMH44 (iShares MSCI UK IMI ESG Leaders UCITS ETF GBP (Dist)) 12,197GBP 1,282,149 -1.8%
2024-12-10 IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc)) 227GBP 30,399 -2.3%
2024-12-10 IE00000EF730 (iShares Europe Equity Enhanced Active UCITS ETF EUR (Acc)) 1,865GBP 237,761 -1.4%
2024-12-10 IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist)) 138GBP 18,481 -2.3%
2024-12-10 IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc)) 138GBP 18,481 -2.3%
Total =35,315,154 GBP 4,072,322,764
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.